
Cognition Therapeutics Reports Third Quarter 2026 Results
The Purchase, New York-based biotech posted a $4.1 million net loss and said its cash supports operations into late 2027.

The Purchase, New York-based biotech posted a $4.1 million net loss and said its cash supports operations into late 2027.